Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 1,322,708 $ 2,020
Prepaid expenses 244,840 35
Other current assets 766,667 0
Total Current Assets 2,334,215 2,055
Other assets 182,472 0
Deferred offering costs 0 429,168
Investments held in the Trust Account 236,091,124 0
Total Assets 238,607,811 431,223
Current Liabilities:    
Accounts payable and accrued expenses 108,017 5,975
Accrued offering costs 0 305,000
Advances from related party 0 101,326
Note payable—Sponsor   86,000
Total Current Liabilities 108,017 498,301
Other long-term liabilities 1,556,000 0
Deferred underwriting commission 6,900,000 0
Total Liabilities 8,564,017 498,301
COMMITMENTS AND CONTINGENCIES (Note 6)
Class A common stock subject to possible redemption; 23,000,000 and no shares outstanding as of June 30, 2022 and December 31, 2021, respectively (at redemption price) 235,992,494 0
Stockholders' deficit:    
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 0 0
Additional paid-in capital 147,167 24,425
Accumulated deficit (6,096,442) (92,078)
Total Stockholders' Deficit (5,948,700) (67,078)
Total Liabilities, Common Stock subject to Possible Redemption and Stockholders' Deficit 238,607,811 431,223
Common Class A [Member]    
Stockholders' deficit:    
Common Stock, Value, Issued 0 0
Common Class B [Member]    
Stockholders' deficit:    
Common Stock, Value, Issued $ 575 $ 575